BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

510 related articles for article (PubMed ID: 25749534)

  • 1. Clinicopathologic characteristics and outcomes of renal thrombotic microangiopathy in anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis.
    Chen SF; Wang H; Huang YM; Li ZY; Wang SX; Yu F; Zhao MH; Chen M
    Clin J Am Soc Nephrol; 2015 May; 10(5):750-8. PubMed ID: 25749534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Serum C3 Concentration and Histologic Signs of Thrombotic Microangiopathy with Outcomes among Patients with ANCA-Associated Renal Vasculitis.
    Manenti L; Vaglio A; Gnappi E; Maggiore U; Allegri L; Allinovi M; Urban ML; Delsante M; Galetti M; Nicastro M; Pilato FP; Buzio C
    Clin J Am Soc Nephrol; 2015 Dec; 10(12):2143-51. PubMed ID: 26542163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glomerular Immune Deposition in MPO-ANCA Associated Glomerulonephritis Is Associated With Poor Renal Survival.
    Lin W; Shen C; Zhong Y; Ooi JD; Eggenhuizen P; Zhou YO; Luo H; Huang J; Chen JB; Wu T; Meng T; Xiao Z; Ao X; Peng W; Tang R; Yin H; Xiao X; Zhou Q; Xiao P
    Front Immunol; 2021; 12():625672. PubMed ID: 33841408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of Renal Outcomes in Sclerotic Class Anti-Neutrophil Cytoplasmic Antibody Glomerulonephritis.
    Menez S; Hruskova Z; Scott J; Cormican S; Chen M; Salama AD; Alasfar S; Little MA; Safrankova H; Honsova E; Tesar V; Geetha D
    Am J Nephrol; 2018; 48(6):465-471. PubMed ID: 30472700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk Factors for Renal Survival in Chinese Patients with Myeloperoxidase-ANCA-Associated GN.
    Chen Y; Bao H; Liu Z; Liu X; Gao E; Zeng C; Zhang H; Liu Z; Hu W
    Clin J Am Soc Nephrol; 2017 Mar; 12(3):417-425. PubMed ID: 28148558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of treatment outcomes in ANCA-associated vasculitis with severe kidney failure.
    Lee T; Gasim A; Derebail VK; Chung Y; McGregor JG; Lionaki S; Poulton CJ; Hogan SL; Jennette JC; Falk RJ; Nachman PH
    Clin J Am Soc Nephrol; 2014 May; 9(5):905-13. PubMed ID: 24578329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pauci-immune glomerulonephritis in children: a clinicopathologic study of 21 patients.
    Khalighi MA; Wang S; Henriksen KJ; Bock M; Keswani M; Chang A; Meehan SM
    Pediatr Nephrol; 2015 Jun; 30(6):953-9. PubMed ID: 25669759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome Predictors of Biopsy-Proven Myeloperoxidase-Anti-Neutrophil Cytoplasmic Antibody-Associated Glomerulonephritis.
    Ge Y; Yang G; Yu X; Sun B; Zhang B; Yuan Y; Zeng M; Wang N; Mao H; Xing C
    Front Immunol; 2020; 11():607261. PubMed ID: 33613528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors for outcomes in patients with severe ANCA-associated glomerulonephritis who were dialysis-dependent at presentation: a study of 89 cases in a single Chinese center.
    Li ZY; Gou SJ; Chen M; Zhao MH
    Semin Arthritis Rheum; 2013 Apr; 42(5):515-21. PubMed ID: 23332902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and histologic determinants of renal outcome in ANCA-associated vasculitis: A prospective analysis of 100 patients with severe renal involvement.
    de Lind van Wijngaarden RA; Hauer HA; Wolterbeek R; Jayne DR; Gaskin G; Rasmussen N; Noël LH; Ferrario F; Waldherr R; Hagen EC; Bruijn JA; Bajema IM
    J Am Soc Nephrol; 2006 Aug; 17(8):2264-74. PubMed ID: 16825335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interstitial Immunostaining and Renal Outcomes in Antineutrophil Cytoplasmic Antibody-Associated Glomerulonephritis.
    Geetha D; Sethi S; De Vriese AS; Specks U; Kallenberg CGM; Lim N; Spiera R; St Clair EW; Merkel PA; Seo P; Monach PA; Lepori N; Fessler BJ; Langford CA; Hoffman GS; Sharma R; Stone JH; Fervenza FC;
    Am J Nephrol; 2017; 46(3):231-238. PubMed ID: 28881339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical features and outcomes of ANCA-associated renal vasculitis.
    Seck SM; Dussol B; Brunet P; Burtey S
    Saudi J Kidney Dis Transpl; 2012 Mar; 23(2):301-5. PubMed ID: 22382223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive Analysis of Sex Differences at Disease Manifestation in ANCA-Associated Glomerulonephritis.
    Tampe D; Korsten P; Ströbel P; Hakroush S; Tampe B
    Front Immunol; 2021; 12():736638. PubMed ID: 34630417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of a histopathologic classification scheme for antineutrophil cytoplasmic antibody-associated glomerulonephritis.
    Nohr E; Girard L; James M; Benediktsson H
    Hum Pathol; 2014 Jul; 45(7):1423-9. PubMed ID: 24784920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ANCA-associated vasculitis in scleroderma: A renal perspective
.
    Kant S; Shah AA; Hummers LK; Wigley FM; Geetha D
    Clin Nephrol; 2018 Dec; 90(6):413-418. PubMed ID: 30106367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ANCA positive crescentic glomerulonephritis outcome in a Central East European cohort: a retrospective study.
    Andreiana I; Stancu S; Avram A; Taran L; Mircescu G
    BMC Nephrol; 2015 Jun; 16():90. PubMed ID: 26123651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Organisation of lymphocytic infiltrates in ANCA-associated glomerulonephritis.
    Brix SR; Noriega M; Herden EM; Goldmann B; Langbehn U; Busch M; Jabs WJ; Steinmetz OM; Panzer U; Huber TB; Stahl RAK; Wiech T
    Histopathology; 2018 Jun; 72(7):1093-1101. PubMed ID: 29453894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ANCA-associated crescentic glomerulonephritis with mesangial IgA deposits.
    Haas M; Jafri J; Bartosh SM; Karp SL; Adler SG; Meehan SM
    Am J Kidney Dis; 2000 Oct; 36(4):709-18. PubMed ID: 11007672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extended versus standard azathioprine maintenance therapy in newly diagnosed proteinase-3 anti-neutrophil cytoplasmic antibody-associated vasculitis patients who remain cytoplasmic anti-neutrophil cytoplasmic antibody-positive after induction of remission: a randomized clinical trial.
    Sanders JS; de Joode AA; DeSevaux RG; Broekroelofs J; Voskuyl AE; van Paassen P; Kallenberg CG; Tervaert JW; Stegeman CA
    Nephrol Dial Transplant; 2016 Sep; 31(9):1453-9. PubMed ID: 27242368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternative complement pathway activation products in urine and kidneys of patients with ANCA-associated GN.
    Gou SJ; Yuan J; Wang C; Zhao MH; Chen M
    Clin J Am Soc Nephrol; 2013 Nov; 8(11):1884-91. PubMed ID: 24115193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.